Showing results (1-10 of 106) with videos related to
Sort By:
Pageof 11
Drugs|June 12, 2001
Aminoglycoside adaptive resistance: importance for effective dosage regimensM L Barclay, E J BeggBritish Journal of Clinical Pharmacology|June 1, 1995
Aminoglycosides--50 years onE J Begg, M L BarclayClinical Pharmacokinetics|July 1, 1994
What is the evidence for once-daily aminoglycoside therapy?M L Barclay, E J Begg, K G HicklingAntimicrobial Agents and Chemotherapy|September 1, 1992
Adaptive resistance following single doses of gentamicin in a dynamic in vitro modelM L Barclay, E J Begg, S T ChambersBritish Journal of Clinical Pharmacology|June 1, 1995
A suggested approach to once-daily aminoglycoside dosingE J Begg, M L Barclay, S B DuffullBritish Journal of Clinical Pharmacology|March 12, 1999
The therapeutic monitoring of antimicrobial agentsE J Begg, M L Barclay, C J KirkpatrickBritish Journal of Clinical Pharmacology|September 21, 2001
The therapeutic monitoring of antimicrobial agentsE J Begg, M L Barclay, C M KirkpatrickClinical Pharmacokinetics|March 27, 1999
Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored?M L Barclay, C M Kirkpatrick, E J BeggAntimicrobial Agents and Chemotherapy|January 1, 1995
Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitroM L Barclay, E J Begg, S T Chambers, et al.Australian and New Zealand Journal of Medicine|June 1, 1995
Experience of once-daily aminoglycoside dosing using a target area under the concentration-time curveM L Barclay, S B Duffull, E J Begg, et al.Pageof 11